🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy in which ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07619898
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
The purpose of this study is to determine whether Infliximab (monoclonal an...
Status
Completed
Location
University Hospitals Birmingham NHS Foundation Trust
Start Date
2003-01
Trial ID
NCT00753103
Cytomegalovirus is the most important opportunistic infection after kidney ...
Status
Unknown
Location
Hospital do Rim
Start Date
2015-09
Trial ID
NCT02671318
Treatments Being Tested
To assess the efficacy and safety of Abatacept as an immunosuppressive trea...
Status
Completed
Location
UZLeuven
Start Date
2019-04-01
Trial ID
NCT03871361
Treatments Being Tested
Ocular mucous membrane pemphigoid (MMP) is an autoimmune, scarring conjunct...
Status
Terminated
Location
Barnes Jewish Hospital / Washington University in St. Louis
Start Date
2022-02-21
Trial ID
NCT05263505
Treatments Being Tested